Data Characteristics in this Domain
Autoimmune disease pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE) data, patient reports (collected via online platforms or phone), electronic health record (EHR) systems, and drug regulatory agency adverse event databases. Data updates frequently. Clinical trial data may update weekly or monthly, while post-market data streams in continuously. Document structures vary, including structured case report forms (CRFs), semi-structured free-text reports (e.g., patient complaints, physician diagnoses), imaging reports, and laboratory test results. Fields include patient demographics, diagnoses, medication history (including non-autoimmune drugs), adverse event descriptions (Onset, Term, Outcome), causality assessment, severity grading, and interventions. Doses are typically in milligrams (mg) or International Units (IU). Time units are commonly days, weeks, or months. Laboratory indicators use their respective international standard units.
Constraints Imposed by Data Characteristics on Workflow Orchestration
The diversity and high update frequency of autoimmune pharmacovigilance data demand real-time and robust workflows. The high proportion of free-text reports requires workflows to integrate strong natural language processing (NLP) capabilities. These capabilities extract adverse event information, drug names, dosage, and temporal relationships accurately, then standardize them. Multi-source heterogeneous data requires workflows with flexible data ingestion and fusion capabilities to ensure unified processing of data from different channels. For example, structured data from EHRs and unstructured data from patient reports need integration through unified entity recognition and event extraction modules. The complexity of autoimmune diseases often leads to multi-system involvement in adverse events, making them difficult to distinguish from disease symptoms. This necessitates incorporating medical knowledge graphs or expert rules into event correlation analysis and causality determination steps to aid judgment. The sensitive nature of the data also imposes strict requirements on workflow permission management and data anonymization.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
maxContext | 3000–4000 characters | Ensures complete capture of adverse event descriptions, medication history, and relevant clinical details, preventing truncation of critical information. |
Chunk size (Segment Length) | 500–700 characters | Balances semantic completeness with model processing efficiency, reducing information overload or context loss in a single segment. |
Recall count (Recall Count) | Top 8–12 entries | Autoimmune adverse reactions relate to multiple factors; increasing recall count helps cover potential associated information. |
Similarity threshold (Similarity Threshold) | 0.75–0.85 | Balances recall and precision, avoiding interference from irrelevant information while not missing potentially weak associations. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Addresses parsing requirements for documents containing large amounts of free text or complex structures, preventing file parsing timeouts. |
Rerank result count (Reranked Return Count) | Top 5 entries | Further optimizes results based on initial recall, focusing on the most relevant adverse event information. |
Common Pitfalls
- Key fields like adverse event onset time and duration are empty after data import. This occurs because time expressions in original free text are diverse and lack sufficient entity recognition and standardization.
- Workflows experience timeouts or memory overflow errors when processing large volumes of patient reports. This happens because parameters like
PARSE_FILE_TIMEOUT_SECONDSare set too low, failing to accommodate the complex parsing of unstructured text. - Adverse reaction monitoring results for a specific autoimmune drug fail to effectively link to previously known rare adverse events. This is due to a
Similarity threshold(similarity threshold) set too high or an overly conservative knowledge base recall strategy, leading to missed weak associations or rare events.
Validation of Configuration
- Select a batch of test data containing typical adverse event reports. Run the workflow and verify the accuracy of key information extraction (e.g., drug names, adverse events, onset times) in the output.
- Simulate high-concurrency data input scenarios. Monitor workflow response times and resource utilization to ensure no timeouts or crashes during actual operation.
- Periodically compare adverse events identified by the workflow with manual review results. Calculate precision and recall, and define an acceptable error range based on business requirements.
- Randomly sample a percentage of workflow processing results. Check for the inclusion of specific medical terms and pathological descriptions related to autoimmune diseases to confirm the effectiveness of knowledge base recall and reranking.
Note: The values provided are common starting points. Measure them against specific data samples to optimize performance.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.